MusclePharm Inks Deal With NFL Superstar, 49er All-Pro Patrick Willis

DENVER, Jan. 12, 2012 /PRNewswire/ -- MusclePharm Corporation, a Nevada corporation ("MusclePharm" or the "Company") (OTCBB: MSLP), an expanding U.S. nutritional supplement company, is pleased to announce that it has signed San Francisco 49er superstar linebacker Patrick Willis.

The NFL standout has been a perennial All-Pro selection and is also a five-time Pro Bowl selection.

A two-time All-American at Mississippi, the first-round draft pick of the 49ers in 2007 has quickly become one of the top defensive players in the NFL.

In fact, an ESPN.com expert vote, Willis was named the NFL's best linebacker and the fourth-best defensive player.

In addition to his tremendous on-field success, Willis' rigorous fitness regimen and noted work ethic also makes him an ideal match with MusclePharm and its healthy lifestyle vision.

Willis' social media following includes nearly 105,000 fans on Twitter as well, which fits in perfectly with MusclePharm's impressive and strong social media presence.

"I love the fact that I can partner with a company that is developing cutting edge products that help me train harder and perform to the best of my abilities," NFL Superstar Patrick Willis said. "MusclePharm takes the guess work out of using supplements because I know they take the time to test all their products above and beyond what is required for athletes.  MusclePharm is the Athletes Company and I am excited to join the team."

MusclePharm, which is the official nutritional supplement provider of the Ultimate Fighting Championship (UFC), has also inked deals with NFL superstars Michael Vick and Chad Ochocinco in 2011.

MusclePharm continues to grow at an impressive rate as well, setting a monthly company sales record ($2,700,000) in November.

About MusclePharm Corporation

Headquartered in Denver, Colorado, MusclePharm is a healthy life-style company that develops and manufactures a full line of NSF International approved nutritional supplements that are 100% free of banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than one hundred elite professional athletes from various professional sports leagues including the National Football League, Mixed Martial Arts, and Major League Baseball. The Company's products address all categories of an active lifestyle, including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets, including GNC and Vitamin Shoppe. MusclePharm products are also sold in over 100 online stores, including bodybuilding.com, Amazon.com and Vitacost.com. For more information, please visit www.musclepharm.com.

Forward Looking Statements   

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Investor Contact:
Cory Gregory
President
303-396-6100
http://www.musclepharm.com

SOURCE MusclePharm Corporation